SORT BY Relevancy
When should patients start asking about involving an oncologist in their care, how can we manage quality of life issues while being treated for advanced, metastatic, and castration-resistant prostate cancer? We are discussing how to manage advanced and late stage prostate cancer with Dr Maha Hussain and panelists. The panel of Mike Scott, Tony Crispino, Richard Davis and Jan Manarite, will also be touching upon the results of important clinical trials from the upcoming GU oncology meeting.
Dr. Maha Hussain is a tenured Professor of Medicine and Urology at the University of Michigan. She is the Associate Director for Clinical Research at the University of Michigan Comprehensive Cancer Center (UMCC), the Co-Leader of its Prostate Cancer/GU Oncology Program and the Associate Chief for Clinical Research at the Division of Hematology/ Oncology. Dr. Hussain is an internationally renowned clinical researcher and an expert in genitourinary malignancies particularly prostate and bladder cancers.
On this show we have the Associate Director, Department of Urology, Roswell Park Cancer Institute Dr. James Mohler discussing the recent NCCN guidelines for prostate cancer treatment and the latest research available to us that can help diagnose high risk forms of prostate cancer and avoid unnecessary treatments for low risk forms. Tune in to get a better understanding of prostate cancer treatments and its management.
On the panel are Mike Scott, Tony Crispino and Paul Carpenter.
Al Brown, prostate cancer survivor and organizer of Time4the99, a prostate cancer advocacy group returns following the organization's fundraiser gala held October 20th in Chicago.
Al answers your questions about prostate cancer "live" on the air for a full hour. "The 99" share how they are joining together nationally. We, too, can get involved in the movement to save men's lives from prostate cancer.
Join us! Saturday, October 26, 2013 9 AM - 10AM.
Host Lori Wilk introduces you to the Prostate Cancer Nuts and the brand new website to offer encouragement and support for those who either have been diagnosed with prostate cancer, their love ones, or you want to know more and hear stories about what life and marriage has been life and the challenges we've faced that we want to share with you. We've even got free tips http://www.prostatecancernuts.com
James Smolev, MD, chief of Urology at MedStar Good Samaritan Hospital will visit with Anna's Journey to discuss the importance of early detection and the possibility of a 90+% chance of recovery from Prostate Cancer.
As September is Prostate Cancer Awareness... and following this past weekend's big walk for Prostate Cancer, Anna's Journey is doing more to help raise that awareness... with the help of Dr. Smolev, listeners will have the opportunity to share this info with all those in their family, with friends and anyone else who may need to hear it.
On this Saturday Episode of The Beautiful Butterfly Show we will be Discussing Prostate Cancer Awareness. Even in 2013 we have Men whom are still afraid to go to the doctor. Its time for us to start encouraging our Men to act on their Health.There are alot of venues offered to women for a number of issues , but when it comes to men's health, their issues are not really spotlighted. Tune into and be prepared to take notes on Prostate Screening, and Signs of Prostate Cancer!
Tom Edwards and I discuss what he encountered after being diagnosed with Prostate Cancer. Tom gives us a first hand look into the challenges he encountered. What is also dicussed is why living the healthy lifestyle may not have prevented this but it did give him options.
For more of the medical side of Prostate Cancer visit, http://www.cancer.gov/cancertopics/types/prostate
Brian Cohen DTM Strategies of Success www.briansos.com 631-255-3581 firstname.lastname@example.org
2 HUGES ISSUES IS IT NOT..WE WILL DISCUSS THE ROLE OF STRESS MANAGEMENT IN HELPING TOWARD THE CURE..LOTS TO GO OVER..TUNE IN
Dr. Ian Thompson is Professor, Glenda and Gary Woods Distinguished Chair in GU Oncology at The University of Texas Health Science Center, San Antonio. Dr. Ian Thompson received his undergraduate degree from West Point and his M.D. degree from Tulane University. After a Residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Thompson has published over 400 scientific papers, several dozen book chapters, and has edited five textbooks in medicine and surgery. He currently serves as Vice-Chair of the Early Detection Research Network of the National Cancer Institute and is Chair of the Genitourinary Committee of the Southwest Oncology Group, the largest clinical trials organization supported by the National Cancer Institute. Dr. Thompson is the Principal Investigator of the San Antonio Center for Biomarkers Of Risk of Prostate Cancer. This cohort study, with up to 8 years of followup, currently follows over 3,600 men for development of prostate cancer and has been the source of many recent important developments in the early detection of prostate cancer.
Our prostate cancer panels are conducted in association with Prostate Cancer International and Prostate Cancer Foundation.
RSVP here (or) mail email@example.com
Join Al Brown, prostate cancer survivor, advocate and dynamic speaker in a candid discussion about his experience with prostate cancer.
Do you know what prostate cancer really is? Are wearing diapers and no sex after prostate cancer the truth or a myth? Find out what testing and treatment is really like. Black men are dying at a rate 2.5 times greater than white men. Learn what is being done to save men from this highly curable, yet # 1 killer.
Interview Judith Desjardins
Topics of conversation:
Her upbringing’s influence on her writing
Her journey as caregiver through her husband’s cancer
How writing helped her coping with her husband’s illness
Writing a second book after a successful first book
Becoming an Indie Author
We were honored to feature Dr. Laurence Klotz, an acknowledged authority on active surveillance for the management of low-risk prostate cancer. Dr. Klotz is Professor in the Department of Surgery, University of Toronto Division of Urology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Dr. Klotz and panelists discussed evidence supporting value of active surveillance as a management strategy for men who are diagnosed with low- or very low-risk forms of prostate cancer. Dr. Klotz spoke particularly about factors that are key to the high-quality implementation of active surveillance, including accumulating evidence that true Gleason 6 disease is not associated with any significant risk for metastasis, importance of early identification of patients who do, in fact, have real risk for disease progression over time, are therefore not good candidates for active surveillance, and managing these patients, evolving strategies to minimize need for overly frequent (i.e., annual) biopsies, including potential role of multiparametric MRIs and new biomarkers, as also whether active surveillance is appropriate for a subset of men with Gleason 3 + 4 = 7 disease who have a very small volume Gleason pattern 4 disease.
On the panel were Mike Scott, Thomas N. Krik, Tony Crispino and Walter Green Jr.
Join Host Live Chats
- WGAG Radio (13 chatters)
- IWS Radio (11 chatters)
- Parkinsons Recovery (6 chatters)
- The Cosmic Citizen (6 chatters)
- Gnosis Kardia (4 chatters)
- Radio Jihad Network (4 chatters)
- ROADTOSTARDOM RADIO (1 chatters)
- SIXEYES RADIO (1 chatters)
- HisWordHisWay (1 chatters)
- Freedom Talk Radio Free Hosts (1 chatters)